This somehow mirrors the challenges of Psychiatry as a field in categorizing debilitating disorders (with overlapping symptoms and varied underlying mechanisms) as opposed to normal behavior
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Skinfood's first antioxidant pad, stop the time of your skin with proven antioxidant efficacy and durability
Available: Finch PW, Cross LJM, McAuley DF, Farrell CL
Contraindications Do not use in animals with known hypersensitivity to the active ingredient
It also works well alongside hydrating serums